SE462100B - Komposition och dess anvaendning i ett tvaa- eller flerfassystem - Google Patents

Komposition och dess anvaendning i ett tvaa- eller flerfassystem

Info

Publication number
SE462100B
SE462100B SE8503742A SE8503742A SE462100B SE 462100 B SE462100 B SE 462100B SE 8503742 A SE8503742 A SE 8503742A SE 8503742 A SE8503742 A SE 8503742A SE 462100 B SE462100 B SE 462100B
Authority
SE
Sweden
Prior art keywords
molecular weight
polyethylene glycol
phase
average molecular
dextran
Prior art date
Application number
SE8503742A
Other languages
English (en)
Swedish (sv)
Other versions
SE8503742L (sv
SE8503742D0 (sv
Inventor
E E Brown
G O Johansson
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE8503742A priority Critical patent/SE462100B/sv
Publication of SE8503742D0 publication Critical patent/SE8503742D0/xx
Priority to DE19863625266 priority patent/DE3625266A1/de
Priority to US06/893,864 priority patent/US4740304A/en
Priority to JP61186123A priority patent/JPS6296541A/ja
Priority to GB8619262A priority patent/GB2179952B/en
Priority to FR868611437A priority patent/FR2591606B1/fr
Publication of SE8503742L publication Critical patent/SE8503742L/
Publication of SE462100B publication Critical patent/SE462100B/sv

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/24Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polyethers (AREA)
SE8503742A 1985-08-08 1985-08-08 Komposition och dess anvaendning i ett tvaa- eller flerfassystem SE462100B (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8503742A SE462100B (sv) 1985-08-08 1985-08-08 Komposition och dess anvaendning i ett tvaa- eller flerfassystem
DE19863625266 DE3625266A1 (de) 1985-08-08 1986-07-25 Mittel zur verwendung in einem zwei- oder mehrphasensystem
US06/893,864 US4740304A (en) 1985-08-08 1986-08-06 Composition for use in a twophase or multiphase system
JP61186123A JPS6296541A (ja) 1985-08-08 1986-08-06 生物学的物質の抽出、純化、濃縮または分離用の2相または多相系に使用するための組成物
GB8619262A GB2179952B (en) 1985-08-08 1986-08-07 Composition for use in a twophase or multiphase system
FR868611437A FR2591606B1 (fr) 1985-08-08 1986-08-07 Composition a utiliser dans un systeme biphasique ou multiphasique pour l'extraction, la purification, la concentration et/ou la separation de substances biologiques.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8503742A SE462100B (sv) 1985-08-08 1985-08-08 Komposition och dess anvaendning i ett tvaa- eller flerfassystem

Publications (3)

Publication Number Publication Date
SE8503742D0 SE8503742D0 (sv) 1985-08-08
SE8503742L SE8503742L (sv) 1987-02-09
SE462100B true SE462100B (sv) 1990-05-07

Family

ID=20361057

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8503742A SE462100B (sv) 1985-08-08 1985-08-08 Komposition och dess anvaendning i ett tvaa- eller flerfassystem

Country Status (6)

Country Link
US (1) US4740304A (fr)
JP (1) JPS6296541A (fr)
DE (1) DE3625266A1 (fr)
FR (1) FR2591606B1 (fr)
GB (1) GB2179952B (fr)
SE (1) SE462100B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132763A (en) * 1988-10-20 2000-10-17 Polymasc Pharmaceuticals Plc Liposomes
US5349052A (en) * 1988-10-20 1994-09-20 Royal Free Hospital School Of Medicine Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
GB8824591D0 (en) 1988-10-20 1988-11-23 Royal Free Hosp School Med Fractionation process
US5101018A (en) * 1989-06-12 1992-03-31 International Minerals & Chemical Corp. Method for recovering recombinant proteins
US5047511A (en) * 1989-08-28 1991-09-10 Pitman-Moore, Inc. Method for recovering recombinant proteins
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
SE9500778D0 (sv) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
SE9603068D0 (sv) * 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
SE9603304D0 (sv) * 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
SE9603303D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
EP0942935A1 (fr) * 1996-09-11 1999-09-22 Pharmacia & Upjohn Aktiebolag Technique de purification d'alipoproteine et composition a utiliser dans le cadre de cette technique
EP0842950B1 (fr) * 1996-11-18 2002-11-13 Societe Des Produits Nestle S.A. Concentration de polysaccharides
WO2012024688A1 (fr) 2010-08-20 2012-02-23 President And Fellows Of Harvard College Systèmes multiphases et leurs utilisations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077054A (en) * 1959-06-22 1963-02-12 Scholten Chemische Fab Erosion control
US3219519A (en) * 1963-03-28 1965-11-23 Hercules Powder Co Ltd Starch ethers in paper
JPS538750B2 (fr) * 1971-08-18 1978-03-31
US3725386A (en) * 1971-12-06 1973-04-03 Staley Mfg Co A E Method for purifying crude, dry granular reacted cold water swelling hydroxypropyl starch derivatives
JPS5027884A (fr) * 1973-07-12 1975-03-22
GB1514720A (en) * 1974-10-07 1978-06-21 Secr Defence Preparation of hydroxyethyl starch
JPS5233893A (en) * 1975-09-11 1977-03-15 Seiwa Kasei Kk Method of producing adsorbent
US4277364A (en) * 1975-12-22 1981-07-07 The United States Of America As Represented By The Secretary Of Agriculture Encapsulation by entrapment
NL165401C (nl) * 1977-01-06 1981-04-15 Helmes Maschf Bv Machine voor het frezen van een pen aan het kopse uiteinde van een houten werkstuk en werkwijze voor het bedrijven van deze machine.
US4171403A (en) * 1977-01-28 1979-10-16 Owens-Corning Fiberglas Corporation Glass fiber coated with a hydroxy-ethylated starch, a tertiary amine etherified starch, and a methyl methacrylate latex polymer or co-polymer
AT348548B (de) * 1977-04-08 1979-02-26 Laevosan Gmbh & Co Kg Verfahren zur herstellung von alsblutplasma- expander geeignerter hydroxyaethylstaerke
DE2819969A1 (de) * 1978-05-08 1979-11-22 Behringwerke Ag Verwendung von hydroxyaethylstaerke zur anreicherung und stabilisierung von antihaemophilem globulin (faktor viii)
DE2908436A1 (de) * 1979-03-05 1980-09-25 Fresenius Chem Pharm Ind Kolloidales gefrierschutzmittel
US4803071A (en) * 1980-02-11 1989-02-07 National Starch And Chemical Corporation Hair care compositions
EP0063146A1 (fr) * 1980-10-23 1982-10-27 MATTIASSON, Bo Gustav Procedes de conversion biologique et chimique dans un systeme a phase liquide
US4361669A (en) * 1981-08-17 1982-11-30 Champion International Corporation Coating compositions comprising a reaction product of a dispersed _hydroxy-alkyl modified starch product and a hydrolyzed styrene maleic anhydride copolymer
DE3141499A1 (de) * 1981-10-20 1983-04-28 Wolff Walsrode Ag, 3030 Walsrode Verfahren zur herstellung von hydroxypropylstaerke
US4431800A (en) * 1982-03-30 1984-02-14 General Foods Corporation Process for hydroxypropylating starch
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser

Also Published As

Publication number Publication date
SE8503742L (sv) 1987-02-09
DE3625266A1 (de) 1987-02-19
SE8503742D0 (sv) 1985-08-08
GB8619262D0 (en) 1986-09-17
JPS6296541A (ja) 1987-05-06
FR2591606B1 (fr) 1990-03-02
GB2179952A (en) 1987-03-18
FR2591606A1 (fr) 1987-06-19
US4740304A (en) 1988-04-26
GB2179952B (en) 1989-09-13

Similar Documents

Publication Publication Date Title
SE462100B (sv) Komposition och dess anvaendning i ett tvaa- eller flerfassystem
DE69034220T2 (de) Nukleotid-Sequenzen von HIV-1, HIV-2 and SIV Retrovirusgenommen, ihre Verwendung zur Amplifizierung von diesen Retrovieren und zur in vitro Diagnostik von diesen Viren verursachten Infektion
Kostraba et al. Differential activation of transcription of chromatin by non-histone fractions
Edstrom et al. The base composition of ribonucleic acid in lampbrush chromosomes, nucleoli, nuclear sap, and cytoplasm of Triturus oocytes
US5300635A (en) Quaternary amine surfactants and methods of using same in isolation of nucleic acids
DE3856428T2 (de) Transkriptionbasierte Nukleinsäure-Verstärkungs/Nachweissysteme
Daròs et al. Replication of avocado sunblotch viroid: evidence for a symmetric pathway with two rolling circles and hammerhead ribozyme processing.
JP3615545B2 (ja) 第四級アンモニウム塩界面活性剤及びそのrnaの単離剤
McMeekin Serum albumin. I. The preparation and properties of crystalline horse serum albumin of constant solubility
Crippa et al. Persistence in early amphibian embryos of informational RNA's from the lampbrush chromosome stage of oögenesis.
Richardson Rho factor function in T4 RNA transcription
WO2005044836A2 (fr) Composes nucleotidiques macromoleculaires et leurs procedes d'utilisation
AU759401B2 (en) Improved method for the isolation of nucleic acid
WO2021037075A1 (fr) Procédé, composition et kit d'enrichissement à sélection de taille d'acides nucléiques
DK174784B1 (da) Kvantificering af nukleinsyremolekyler og reagenssæt dertil
DE69028951T2 (de) Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen
DE68924601T2 (de) Reinigung von q-beta-replicase.
DE69931928T2 (de) Reversibel inhibierende sonden
Alberts [74] Fractionation of nucleic acids by dextran-polyethylene glycol two-phase systems
Tracy et al. Bean yellow mosaic, clover yellow vein, and pea mosaic are distinct potyviruses: evidence from coat protein gene sequences and molecular hybridization involving the 3′ non-coding regions
CN103314290B (zh) 核酸链的分离方法
TWI691595B (zh) 選擇性分離核酸之方法及套組
DE602004003163T2 (de) Verfahren zur Bereitstellung von Proben zum Nachweis
Beckmann et al. Binding of the termination factor ϱ to DNA
DE19900851A1 (de) Oligonucleotid-Antikoagulantien mit schnell revertierbarer Thrombinbindung

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8503742-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8503742-2

Format of ref document f/p: F